|
1
|
Yang J, Huang YH, Zhong W, Gong X, Chen Y, Chen Z, Jin H, Yan S, Huang L, Yuan CZ, Lou M. Effectiveness of intravenous recombinant plasminogen activator treatment in Chinese patients with acute ischaemic stroke aged over 80 years: a retrospective cohort study. Stroke Vasc Neurol 2025:svn-2024-004004. [PMID: 40312065 DOI: 10.1136/svn-2024-004004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2025] [Accepted: 04/16/2025] [Indexed: 05/03/2025] Open
Abstract
BACKGROUND Risks and benefits of intravenous recombinant tissue plasminogen activator (rt-PA) remain unclear among elderly patients with acute ischaemic stroke (AIS). This study investigated 1-year clinical outcomes of intravenous rt-PA treatment in Chinese patients aged >80 years with AIS. METHODS This retrospective multicentre study included patients with AIS aged >80 years from the Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation stroke registry platform between January 2017 and March 2020 who arrived at the hospital within 4.5 hours of symptom onset. Patients who received intravenous rt-PA were propensity score-matched (1:1) by baseline characteristics with those who did not receive reperfusion therapy. The primary outcome was modified Rankin scale (mRS) score 0-1 at 1 year; secondary outcomes were any intracranial haemorrhage (ICH) and all-cause mortality during hospitalisation, mRS 0-2, mRS score distribution and all-cause mortality at 1 year. RESULTS The analysis included 1560 propensity score-matched elderly patients (intravenous rt-PA, n=780; non-reperfusion, n=780). At 1 year, the intravenous rt-PA group had a higher proportion of patients with mRS 0-1 (27.7% vs 23.8%; OR 1.87, 95% CI 1.35 to 2.59, p<0.001), mRS 0-2 (37.3% vs 33.7%; OR 2.02, 95% CI 1.48 to 2.75, p<0.001) and an overall shift towards better outcomes than placebo (mRS mean±SD score: 3.5±2.4 vs 3.7±2.3; OR 0.77, 95% CI 0.64 to 0.93, p=0.007). No significant differences were observed in any ICH and all-cause mortality during hospitalisation and at 1 year. CONCLUSIONS This study provided real-world evidence for a positive benefit-risk profile of intravenous rt-PA in Chinese patients with AIS aged >80 years. TRIAL REGISTRATION NUMBER NCT05401149.
Collapse
Affiliation(s)
- Jiansheng Yang
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| | - Yu-Hui Huang
- School of Public Health, the Second Affiliated Hospital， Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Wansi Zhong
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| | - Xiaoxian Gong
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| | - Yi Chen
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| | - Zhicai Chen
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| | - Haidi Jin
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| | - Shenqiang Yan
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| | - Liyan Huang
- School of Public Health, the Second Affiliated Hospital， Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Chang-Zheng Yuan
- School of Public Health, the Second Affiliated Hospital， Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
- Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Min Lou
- Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, ZheJiang, China
| |
Collapse
|
|
2
|
Qu C, Chen Y, Liu C, Hu Z, Zhang J, Yan L, Zhang H, Liu Y, Liu W, Cheng Q, Luo P, Liu Z. Burden of Stroke Attributable to Nonoptimal Temperature in 204 Countries and Territories: A Population-Based Study, 1990-2019. Neurology 2024; 102:e209299. [PMID: 38598742 PMCID: PMC11175652 DOI: 10.1212/wnl.0000000000209299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Accepted: 01/30/2024] [Indexed: 04/12/2024] Open
Abstract
BACKGROUND AND OBJECTIVES Stroke attributable to nonoptimal temperature needs more attention with dramatic climate change. The aim of this study was to estimate the global burden and distribution characteristics of the burden. METHODS In this ecological study, we collected data from the Climate Research Unit Gridded Time Series, the World Bank databases, and the Global Burden of Diseases study to estimate the distribution of burden. We used the joinpoint model, decomposition analysis, age-period-cohort model, panel data analysis, and health inequality analysis to assess the different types of stroke burden attributable to different climatic conditions. RESULTS The burden of stroke attributable to nonoptimal temperature continued to grow, and aging was a key factor in this increase. In 2019, 521,031 (95% uncertainty interval [UI] 402,433-663,996) deaths and 9,423,649 (95% UI 7,207,660-12,055,172) disability-adjusted life years [DALYs] attributable to stroke due to nonoptimal temperature were recorded globally. Globally, men (age-standardized mortality rate [ASMR] 7.70, 95% UI 5.80-9.73; age-standardized DALY rate [ASDR] 139.69, 95% UI 102.96-178.54 in 2019) had a heavier burden than women (ASMR 5.89, 95% UI 4.50-7.60; ASDR 96.02, 95% UI 72.62-123.85 in 2019). Central Asia (ASMR 18.12, 95% UI 13.40-24.53; ASDR 327.35, 95% UI 240.24-440.61 in 2019) had the heaviest burden at the regional level. In the national level, North Macedonia (ASMR 32.97, 95% UI 20.57-47.44 in 2019) and Mongolia (ASDR 568.54, 95% UI 242.03-1,031.14 in 2019) had the highest ASMR/ASDR, respectively. Low temperature currently contributes to the main burden (deaths 474,002, 95% UI 355,077-606,537; DALYs 8,357,198, 95% UI 6,186,217-10,801,911 attributable to low temperature vs deaths 48,030, 95% UI 5,630-104,370; DALYs 1,089,329, 95% UI 112,690-2,375,345 attributable to high temperature in 2019). However, the burden due to high temperature has increased rapidly, especially among people aged older than 10 years, and was disproportionately concentrated in low sociodemographic index (SDI) regions such as Africa. In addition, the rapid increase in the stroke burden due to high temperature in Central Asia also requires special attention. DISCUSSION This is the first study to assess the global stroke burden attributed to nonoptimal temperature. The dramatic increase in the burden due to high temperature requires special attention, especially in low-SDI countries.
Collapse
Affiliation(s)
- Chunrun Qu
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Yu Chen
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Chen Liu
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Zhiwen Hu
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Jingwei Zhang
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Luzhe Yan
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Hao Zhang
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Yifan Liu
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Wanyao Liu
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Quan Cheng
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Peng Luo
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Zhixiong Liu
- From the Department of Neurosurgery (C.Q., Y.C., J.Z., Q.C., Z.L.), National Clinical Research Center for Geriatric Disorders (C.Q., Y.C., J.Z., Q.C., Z.L.), Xiangya Hospital, and XiangYa School of Medicine (C.Q., Y.C., C.L., Z.H., L.Y., Y.L., W.L.), Central South University, Changsha, Hunan; Department of Neurosurgery (H.Z.), The Second Affiliated Hospital, Chongqing Medical University; and Department of Oncology (P.L.), Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| |
Collapse
|
|
4
|
Guo L, Zhang M, Namassevayam G, Wei M, Zhang G, He Y, Guo Y, Liu Y. Effectiveness of health management among individuals at high risk of stroke: An intervention study based on the health ecology model and self-determination theory (HEM-SDT). Heliyon 2023; 9:e21301. [PMID: 37964830 PMCID: PMC10641168 DOI: 10.1016/j.heliyon.2023.e21301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 10/11/2023] [Accepted: 10/19/2023] [Indexed: 11/16/2023] Open
Abstract
Background Stroke is the second leading cause of death in adults worldwide. However, up to 80% of strokes can be prevented by modifying risk factors. Objective The study aims to assess the effectiveness of the Health Ecology Model and Self-Determination Theory (HEM-SDT) based health management intervention among individuals at high risk of stroke. Methods A randomized controlled trial was conducted in Zhengzhou from May 1st, 2020, to December 31st, 2020. A total of 229 participants were recruited for the study, with 116 individuals at high risk of stroke being randomly assigned to the HEM-SDT health management group, while 113 participants were enrolled in the control group, following their current routine practices. The Generalized Estimating Equation model (GEE) was used to analyze the differences in health knowledge, belief and, behavior between the two groups at the beginning of the intervention, and at 6-month intervals after the intervention. The chi-square test was utilized to assess the control rate of risk factors. Results After 6 months of intervention, there were significant improvements in health knowledge, behavior, and belief among the participants. The study found significant differences in the interaction effects between time and group for health knowledge (Mean, SD = 25.62 ± 3.88, 95%CI: 7.944-9.604, P＜0.001), health belief (Mean, SD = 87.18 ± 14.21, 95%CI: 23.999-29.887, P＜0.001), and health behavior (Mean, SD = 173.28 ± 24.22, 95%CI: 22.332-36.904, P＜0.001). Additionally, the rates of hypertension, hyperglycemia, dyslipidemia, high or medium risk condition of stroke, obesity, hyperhomocysteinemia, smoking, alcohol consumption, and lack of exercise also showed statistical significance (P＜0.05) after the intervention. Conclusion The HEM-SDT health management model improves the health knowledge, behavior, and beliefs in people at high risk of stroke and remarkably it shows improvement in modifiable risk factors. It can be recommended for systematic health management in people at high-risk of stroke.
Collapse
Affiliation(s)
- Lina Guo
- Department of Neurology, National Advanced Stroke Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
| | - Mengyv Zhang
- Department of Neurology, National Advanced Stroke Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
| | - Genoosha Namassevayam
- Department of Neurology, National Advanced Stroke Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Department of Supplementary Health Sciences, Faculty of Health-Care Sciences, Eastern University, Sri Lanka
| | - Miao Wei
- Department of Neurology, National Advanced Stroke Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
| | - Gege Zhang
- Department of Neurology, National Advanced Stroke Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
| | - Yv He
- Department of Neurology, National Advanced Stroke Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Reproductive Medicine Center, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
| | - Yuanli Guo
- Department of Neurology, National Advanced Stroke Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
| | - Yanjin Liu
- Department of Nursing, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China
| |
Collapse
|